Inactive Instrument

News Proteo, Inc. Other OTC

Equities

PTEO

US74369R3084

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

U.S. Special Forces launch counter-terrorism drills with African armies	23-03-01	RE
PROTEO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-07-20	AQ
PROTEO INC : Submission of Matters to a Vote of Security Holders (form 8-K)	20-07-10	AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-06-05	AQ
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-05	CI
PROTEO INC : Other Events (form 8-K)	20-05-12	AQ
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	20-05-07	AQ
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-07	CI
PROTEO INC : Other Events (form 8-K)	20-03-30	AQ
PROTEO INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	20-03-03	AQ
Proteo, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Proteo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-05	CI
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-15	CI
Proteo, Inc. Announces Management Changes	18-11-19	CI
Proteo, Inc. and Proteo Biotech AG Announces Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery	14-11-21	CI
Proteo Inc : Patient recruitment and treatment in Elafin CABG Phase II clinical trial completed	13-11-08	PU
PROTEO INC : Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients	11-08-16	PU
PROTEO INC : Proteo, Inc./ Proteo Biotech AG: Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)	10-06-18	BU
PROTEO : Proteo, Inc./Proteo Biotech AG: Clinical Study in Harvard Reveals Elafin Deficiency in Acute Respiratory Distress Syndrome (ARDS)	09-02-17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Proteo, Inc. Other OTC

Equities

PTEO

US74369R3084

Summary

Filters